A team from the Weizmann Institute of Science in Rehovot, Israel, has reported that it has differentiated naive and primed human pluripotent stem cells into trophoblast cells. The article detailing the work of Sergey Viukov and colleagues was published in an early November 2022 issue of the journal Stem Cell Reports. The authors state that their research will allow for the study of placental development and disorders in vitro. More controversially, they also aim to develop human “synthetic” embryos using these results.
Read More